Search

everythinglearnresearchcommunity

for

Search:↓

Thermus thermophilus extract improves hair growth and scalp health in men with hair loss.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Daily subcutaneous testosterone effectively restores testosterone levels in men.

Effective treatment for hidradenitis suppurativa varies, with antibiotics commonly used and surgery as an option, but no single method is universally successful.

The new clinical trial design is promising but needs real-world trials to test its effectiveness and possible enhancements.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

L-(+)-Tartaric Acid may help increase certain hair growth genes without harming cells.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

Thai regional hospitals need more resources for better efficiency, and investment in quality could help Thailand become a medical tourism hub.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Combining DHT and EDC improves the strength and stability of PADM scaffolds for tissue engineering.

Most patients with Tuberous sclerosis had neurological or skin issues, and over half had psychiatric problems.

Skin cells and immune cells change in a skin condition called hidradenitis suppurativa, and a certain treatment can improve these changes.

TTD patients don't have a higher skin cancer risk because their main issue is with transcription, not DNA repair.

Proactive physical therapy improved mobility, reduced fatigue, and pain in lupus patients.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

New treatments offer hope for better managing hidradenitis suppurativa.

A new hair restoration technology was found to effectively increase hair thickness, density, and growth, while reducing hair loss and improving scalp health, with no side effects.

Allergen-specific immunotherapy can significantly improve hair loss and dermatitis symptoms in severe cases.

3,4,5-tri-O-caffeoylquinic acid promotes hair growth by activating the β-catenin pathway.

The guideline recommends using specific drugs and surgery together for treating hidradenitis suppurativa effectively.

Laser therapy effectively treats all stages of hidradenitis suppurativa, offering a reliable alternative to medication.

TAZ boosts fat cell formation in goat stem cells by activating a specific signaling pathway.

Behavioral interventions, especially habit reversal training, are most effective for treating trichotillomania in children.

Topical PROTACs show promise for treating skin conditions but need better stability and delivery methods.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.